These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5008538)

  • 1. The plasma digoxin concentration, red cell rubidium 86 uptake and control of ventricular rate in patients being digitalized for artrial fibrilation.
    Hibble AG; Grahame-Smith DG
    Clin Sci; 1972 Jan; 42(1):3P. PubMed ID: 5008538
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
    Aronson JK; Grahame-Smith DG; Hallis KF; Hibble A; Wigley F
    Br J Clin Pharmacol; 1977 Apr; 4(2):213-21. PubMed ID: 861136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma digoxin concentration--its relation to digoxin dosage and clinical effects in patients with atrial fibrillation.
    Redfors A
    Br Heart J; 1972 Apr; 34(4):383-91. PubMed ID: 5020715
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.
    Ford AR; Aronson JK; Grahame-Smith DG; Carver JG
    Br J Clin Pharmacol; 1979 Aug; 8(2):125-34. PubMed ID: 486289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of digoxin effect in atrial fibrillation.
    Zener JC; Anggard EE; Harrison DC; Kalman SM
    JAMA; 1973 Apr; 224(2):239-41. PubMed ID: 4739495
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation.
    Galun E; Flugelman MY; Glickson M; Eliakim M
    Chest; 1991 Apr; 99(4):1038-40. PubMed ID: 2009763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the inhibition by digoxin of 86 Rubidium uptake into human red cells.
    Cowie JR
    Med Lab Sci; 1979; 36(4):339-52. PubMed ID: 522620
    [No Abstract]   [Full Text] [Related]  

  • 8. Digoxin and digitoxin in man: influence on rubidium transport in red blood cells in vitro.
    Cohen HC
    Acta Cardiol; 1971; 26(5):443-57. PubMed ID: 5316232
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of digoxin on 86rubidium uptake by erythrocytes from mothers and babies.
    Kelly JG; McMillen RM; McDevitt DG
    Br J Clin Pharmacol; 1983 Jan; 15(1):49-53. PubMed ID: 6849744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in 86-rubidium uptake in erythrocytes of digoxin-treated patients, in heart failure with sinus rhythm. Relationship to clinical effects.
    Zannad F; Royer RJ; Robert J
    Eur J Cardiol; 1981; 12(5):275-84. PubMed ID: 6265219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of digoxin and beta-methyldigoxin on the heart rate of decompensated patients with atrial fibrillation.
    Andersson KE; Johansson BW; Ledermann H; von Schenck H; Thorell JI
    Eur J Clin Invest; 1977 Feb; 7(1):3-6. PubMed ID: 402273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation.
    Goldman S; Probst P; Selzer A; Cohn K
    Am J Cardiol; 1975 May; 35(5):651-5. PubMed ID: 1124719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents.
    Cargnelli G; Domeneghetti F; Ferrari M; Malacini P; Roberti G
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):384-8. PubMed ID: 892956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy.
    Aronson JK; Ford AR; Grahame-Smith DG
    Klin Wochenschr; 1981 Dec; 59(24):1323-32. PubMed ID: 6275162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Problems with digoxin.
    Br Med J; 1975 Jan; 1(5949):49-50. PubMed ID: 1109653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of plasma digitoxin. Comparison between the method by 86 Rb erythrocyte incorporation and radioimmunoassay].
    Chanard J; Bader C; Assailly J; Funck-Brentano JL
    Pathol Biol (Paris); 1973 Sep; 21(7):725-30. PubMed ID: 4270955
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-blockers versus digoxin to control ventricular rate during atrial fibrillation.
    Veloso HH; de Paola AA
    J Am Coll Cardiol; 2005 Jun; 45(11):1905-6; author reply 1906-7. PubMed ID: 15936626
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of metabolites of digoxin and digitoxin on the 86Rb-uptake assay.
    Kaufman JM; Belpaire FM
    Eur J Clin Pharmacol; 1973 Jun; 6(1):54-6. PubMed ID: 4764372
    [No Abstract]   [Full Text] [Related]  

  • 19. Quinidine-digoxin interaction: effect of quinidine on 86Rb-uptake of human erythrocytes.
    Doering W; Belz GG
    Klin Wochenschr; 1981 Jan; 59(2):95-6. PubMed ID: 6259407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.
    Grahame-Smith DG
    Br Med J; 1969 Feb; 1(5639):286-9. PubMed ID: 5762647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.